CatalystWireBeta

eEnergy Group

EAAS · AIM · Industrial Goods and Services · mcap £1.1m · 0.3p 3 open situations →

EV
£11.1m
EV / EBIT
88.0x
Net debt
£1.5m
FCF yield
-40.6%
Revenue
£30.8m
Share price 1y
−94%
Insiders 12m
no deals
Next report
around 29 Apr

Beta Briefing, track record and signals & risks are not ready for eEnergy Group yet.

We follow 960 UK small caps and every one of their announcements – often hundreds per company. 101 companies are already wired into a briefing: browse them.

Timeline · every situation
dots = announcements

Open · 3

Dilutive fundraise

Working capital funding for solar programme

Awaiting shareholder vote; board urging approval

Mace payment delays strained creditor payments, and on 2 Oct 2026 the company set a c.£6.3m placing and subscription at 0.3p. The retail offer on 6 Oct 2026 lifted the total to c.£8.3m. On 16 Oct 2026 the board urged shareholders to vote, calling the raise imperative to keep the company solvent; failure would force a going-concern review. Vote on 23 Oct 2026.

Broker
Canaccord Genuity Limited arranging the placing 30 Sep 2026 ↗
Dilution
New shares are c.88% of enlarged share capital, assuming the retail offer is taken up in full 2 Oct 2026 ↗
Related parties
Harwood Capital subscribes £1.5m; Dr Nigel Burton £250,000; Harwood loan interest stops from the general meeting 2 Oct 2026 ↗
Size
£8.3m gross: Placing, Subscription and Retail Offer 16 Oct 2026 ↗
Board view
Fundraising critical to keep the Company solvent and bring creditors up to date 16 Oct 2026 ↗
If rejected
Fundraising cannot complete; urgent review of financial position and going concern 16 Oct 2026 ↗
  1. 16 Oct 2026 Awaiting shareholder vote; board urging approval
  2. 6 Oct 2026 Retail offer done; trading restored; vote pending
  3. 2 Oct 2026 Placing agreed; retail offer terms to follow
  4. 30 Sep 2026 Placing being arranged; shares suspended
Open the full view – chart and every step →
New CEO / reset

CEO succession

Restructuring largely done; Board cut to three

CEO Sinclair left in May 2026 and CFO Gahan became interim CEO. Chair and directors then resigned, leaving a three-person Board under new Chairman Samuel. The June 2026 restructuring cuts costs by c.£2.0m annualised, with a £0.5m charge in H1, and the management team falls from 10 to 5.

Terms
Departure by mutual agreement; no reason stated 18 May 2026 ↗
Next milestone
Further announcement on permanent CEO in due course; no date given 18 May 2026 ↗
Cost saving
circa £2.0m annualised; about 50% of adjusted operating costs 3 Aug 2026 ↗
Restructuring charge
£0.5m in H1-26 3 Aug 2026 ↗
Pipeline review
investment grade opportunities cut to £66m from £127m 22 Jun 2026 ↗
Permanent CEO
search continues; no date given 3 Aug 2026 ↗

Next: permanent CEO appointment; further non-executive appointment

  1. 3 Aug 2026 Restructuring largely done; Board cut to three
  2. 22 Jun 2026 Interim CEO restructuring costs
  3. 18 May 2026 Interim CEO in place; search under way
Open the full view – chart and every step →
Transformational contract / build-out

NHS EPC funding solution rollout

First EPC secured; wider NHS opportunity
  1. 23 Jan 2026 First EPC secured; wider NHS opportunity
  2. 22 Jan 2026 First EPC awarded; new product launched
Open the full view – chart and every step →

Closed · 2

Upgrade / downgrade cycleProfit upgrade guidance raised · second in 12 months · 15 Dec 2025 – 23 Apr 2026 +9% OverhangDerek Myers selling down holder sold out · 3 Jun 2025 – 21 Aug 2025 −18%

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note